Autolus Therapeutics (AUTL) Long-Term Deferred Tax (2018 - 2025)
Historic Long-Term Deferred Tax for Autolus Therapeutics (AUTL) over the last 7 years, with Q3 2025 value amounting to $2.4 million.
- Autolus Therapeutics' Long-Term Deferred Tax fell 2950.72% to $2.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.4 million, marking a year-over-year decrease of 2950.72%. This contributed to the annual value of $3.2 million for FY2024, which is 574.6% up from last year.
- Autolus Therapeutics' Long-Term Deferred Tax amounted to $2.4 million in Q3 2025, which was down 2950.72% from $2.4 million recorded in Q2 2025.
- In the past 5 years, Autolus Therapeutics' Long-Term Deferred Tax registered a high of $3.4 million during Q3 2024, and its lowest value of $1.4 million during Q3 2021.
- In the last 5 years, Autolus Therapeutics' Long-Term Deferred Tax had a median value of $2.4 million in 2025 and averaged $2.5 million.
- As far as peak fluctuations go, Autolus Therapeutics' Long-Term Deferred Tax surged by 39609.76% in 2021, and later plummeted by 2950.72% in 2025.
- Quarter analysis of 5 years shows Autolus Therapeutics' Long-Term Deferred Tax stood at $1.8 million in 2021, then rose by 13.69% to $2.1 million in 2022, then soared by 47.54% to $3.1 million in 2023, then rose by 5.75% to $3.2 million in 2024, then decreased by 26.24% to $2.4 million in 2025.
- Its Long-Term Deferred Tax stands at $2.4 million for Q3 2025, versus $2.4 million for Q2 2025 and $2.8 million for Q1 2025.